Diagnostic Grifols, a leading medical device provider, implementing an Agile solution to enhance collaboration throughout its product development cycle, sees significant results in time to market and regulation compliance.

Published on 29-Nov-2010

"Improved collaboration accelerates our development time." - Diagnostic Grifols

Customer:
Diagnostic Grifols

Industry:
Electronics

Deployment country:
Spain

Solution:
Agile Software Development

Smarter Planet:
Smart Products, Smarter Healthcare

Overview

Diagnostic Grifols, a leading medical device provider, implementing an Agile solution to enhance collaboration throughout its product development cycle, sees significant results in time to market and regulation compliance.

Business need:
The international scale of this company’s business calls for strict compliance of the software it uses to manage and control the development of its products. And the complexity of its development cycle requires software that can enhance teams’ collaboration to deliver products faster.

Solution:
The solution connects all stages of the development cycle, allowing different developers working on the same project to build and share all regulated product data in a controlled environment. Through enhanced collaboration, teams have flexibility to adapt to changes in regulations and take action on potential conflict. By better anticipating schedules, teams keep investment and profitability on track. Automation of operations documentation allows the company to better support compliance audits.

Benefits:
• Time to market decreased by 20 percent • Error rates significantly reduced

Case Study

About the Company

Diagnostic Grifols is part of a holding company which serves the healthcare industry in over 90 countries around the world. This division’s main activity is to develop medical devices for clinical diagnostics, mainly focused in three critical categories: Blood Banking, Hemostasis and Immunology. These devices must be compliant with FDA (U.S. Food and Drug Administration) regulations. FDA is an agency within the U.S. Department of Health and Human Services responsible for regulating food safety, tobacco products, dietary supplements, medications, vaccines, biopharmaceuticals, medical devices, cosmetics, etc.

The Opportunity
The international scale of this company’s business calls for strict compliance of the software it uses to manage and control the development of its products. And the complexity of its development cycle requires software that can enhance teams’ collaboration to deliver products faster.

What Makes it Smarter
Together with IBM, Diagnostic Grifols implemented an Agile solution to manage the entire development process and enhance collaboration between teams. The solution connects all the stages of the development cycle, allowing different developers working on the same project to build and share all the regulated product data in a controlled environment. Through enhanced collaboration, the teams have flexibility to adapt to changes in regulations and take action on the potential conflict. By better anticipating schedules, the teams can keep investment and profitability on track. And through the automation of operations documentation, the company can better support compliance audits.

Business Results
• Time to market decreased by 20 percent
• Error rates significantly reduced

For more information
Please contact your IBM sales representative or IBM Business Partner. Visit us at:

ibm.com/healthcare

Products and services used

IBM products and services that were used in this case study.

Software:
Rational Change, Rational Synergy, Rational DOORS

Legal Information

© Copyright IBM Corporation 2013 IBM Corporation Software Group Route 100 Somers, NY 10589 Produced in the United States of America April 2013 IBM, the IBM logo, ibm.com, DOORS and Rational are trademarks of International Business Machines Corporation in the United States, other countries or both. If these and other IBM trademarked terms are marked on their first occurrence in this information with a trademark symbol (® or TM), these symbols indicate U.S. registered or common law trademarks owned by IBM at the time this information was published. Such trademarks may also be registered or common law trademarks in other countries. Other product, company or service names may be trademarks or service marks of others. A current list of IBM trademarks is available on the web at “Copyright and trademark information” at www.ibm.com/legal/copytrade.shtml. This document is current as of the initial date of publication and may be changed by IBM at any time. Not all offerings are available in every country in which IBM operates. The client examples cited are presented for illustrative purposes only. Actual performance results may vary depending on specific configurations and operating conditions. THE INFORMATION IN THIS DOCUMENT IS PROVIDED “AS IS” WITHOUT ANY WARRANTY, EXPRESS OR IMPLIED, INCLUDING WITHOUT ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND ANY WARRANTY OR CONDITION OF NONINFRINGEMENT. IBM products are warranted according to the terms and conditions of the agreements under which they are provided.